Jvion buys cognitive computing startup
ORLANDO -- Clinical cognitive specialist Jvion revealed plans to buy Predixion Healthcare here at HIMSS17.
Atlanta-based Jvion said the acquisition brings the Predixion Healthcare IT practice expertise, expands Jvion’s market presence among providers that are already on the path to implementing cognitive science tools, and adds Predixion’s data pools to the existing information sets that feed Jvion’s machine.
Predixion co-founder and CFO Steve DeSantis said the deal will also help Jvion augment its reach to more patient in more care settings.
Jvion offers an appliance featuring search engine cognitive machine capabilities that enables patient-level interventions to predict adverse health events or illness and ultimately determine a path to prevent those — using data providers already have and without the need for a data lake or warehouse, the company said.
“The clinical predictive analytics segment, having gone through the usual hype cycle, has started to show consolidation and we are proud to be leading this phase of market growth and maturity,” Jvion CEO Shantanu Nigam said.
Nigam pointed to Carolinas HealthCare System as a customer Predixion has helped deliver processes and information to nurses that reduced readmission rates.
Jvion also announced that Grady Health System became the first safety-net hospital to implement its Cognitive Clinical Success Machine, and Onslow Memorial Hospital has already saved close to $1 million using the appliance to more effectively allocate provider resources and reduce readmissions.
Predixion raised $42 million prior to the acquisition, $20 million in its third round of investment. The startup is backed by Accenture, EMC, GE VEntures, Software AG and Palomar Ventures, among others. The companies did not disclose terms of the deal.
Jvion is in Booth 4681.
This article is part of our ongoing coverage of HIMSS17. Visit Destination HIMSS17 for previews, reporting live from the show floor and after the conference.